| Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study (NCT04089358) | Children's Oncology Group | 2020-12-07 |
| Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (NCT04462536) | NoNO Inc. | 2020-12-06 |
| Evolocumab in STEMI (NCT06081803) | Sejong General Hospital | 2020-12-05 |
| ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) (NCT04523129) | Novaliq GmbH | 2020-12-05 |
| A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine (NCT05668572) | Beijing Health Guard Biotechnology, Inc | 2020-12-05 |
| A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer (NCT04385433) | Institut du Cancer de Montpellier - Val d'Aurelle | 2020-12-04 |
| Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04671433) | Janssen Research & Development, LLC | 2020-12-04 |
| Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans (NCT04649515) | Tychan Pte Ltd. | 2020-12-04 |
| A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) (NCT04622319) | Daiichi Sankyo | 2020-12-04 |
| Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04794101) | Janssen Research & Development, LLC | 2020-12-04 |
| CBD Oil for Reducing Emotional Impact of COVID-19 (NCT04603781) | University of Texas at Austin | 2020-12-04 |
| Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (NCT03948646) | Botanix Pharmaceuticals | 2020-12-04 |
| A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease (NCT04540497) | Amgen | 2020-12-04 |
| COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction (NCT04420624) | University Hospital, Montpellier | 2020-12-04 |
| Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age (NCT04642079) | Pfizer | 2020-12-04 |
| Cannabidiol and Management of Endometriosis Pain (NCT04527003) | Milton S. Hershey Medical Center | 2020-12-04 |
| An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (NCT04620811) | Allakos Inc. | 2020-12-03 |
| Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction (NCT04798430) | LIB Therapeutics LLC | 2020-12-03 |
| A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency (NCT04615273) | Ascendis Pharma Endocrinology Division A/S | 2020-12-03 |
| Convalescent Plasma for Treatment of COVID-19 (NCT04649879) | Joakim Dillner | 2020-12-03 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) (NCT04548999) | Hoffmann-La Roche | 2020-12-03 |
| CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients (NCT04608266) | Assistance Publique - Hôpitaux de Paris | 2020-12-03 |
| Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia. (NCT04552041) | Materia Medica Holding | 2020-12-03 |
| Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults (NCT04625972) | AstraZeneca | 2020-12-02 |
| Adaptive COVID-19 Treatment Trial 4 (ACTT-4) (NCT04640168) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-12-02 |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 (NCT04613596) | Mirati Therapeutics Inc. | 2020-12-02 |
| Exogenous Ketones for Acutely Decompensated HEart Failure (NCT04698005) | Institute for Clinical and Experimental Medicine | 2020-12-02 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain (NCT04647773) | Haisco Pharmaceutical Group Co., Ltd. | 2020-12-02 |
| The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial (NCT04364815) | University of the Philippines | 2020-12-01 |
| RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease (NCT04616924) | RedHill Biopharma Limited | 2020-12-01 |
| CEUS Evaluation of Hypoxic Ischemic Injury (NCT03549520) | Children's Hospital of Philadelphia | 2020-12-01 |
| Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) (NCT04684524) | Sanofi | 2020-12-01 |
| Letrozole in Tubal Ectopic Pregnancy (NCT04341545) | Queen Mary Hospital, Hong Kong | 2020-12-01 |
| Isotretinoin in Treatment of COVID-19 (NCT04361422) | Tanta University | 2020-12-01 |
| The Containing Coronavirus Disease 19 (COVID-19) Trial (NCT04552379) | Pontificia Universidad Catolica de Chile | 2020-12-01 |
| Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (NCT04682210) | Sun Yat-sen University | 2020-12-01 |
| Comparison of Quadratus Lumborum Block Types (NCT04588389) | University of Massachusetts, Worcester | 2020-12-01 |
| Evaluation of Laser and Tranexamic Acid in Treatment of Melasma (NCT04599205) | Assiut University | 2020-12-01 |
| Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea (NCT02801656) | Memorial University of Newfoundland | 2020-12-01 |
| New Treatment for COVID-19 Using Ethanol Vapor Inhalation . (NCT04554433) | Mansoura University | 2020-12-01 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy (NCT04483700) | Gilead Sciences | 2020-12-01 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee (NCT04044742) | Sorrento Therapeutics, Inc. | 2020-12-01 |
| A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT04594369) | Insmed Incorporated | 2020-12-01 |
| Topical Everolimus in Patients With Tuberous Sclerosis Complex (NCT02860494) | Hospices Civils de Lyon | 2020-12-01 |
| SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia (NCT04528095) | Shanghai Mental Health Center | 2020-12-01 |
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss (NCT04558268) | Soroka University Medical Center | 2020-12-01 |
| A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE (NCT04656613) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-12-01 |
| Simplified vs Conventional Drilling Protocol for Implant Placment (NCT06780956) | Universidad Católica San Antonio de Murcia | 2020-12-01 |
| Intravenous Thyroxine for Heart-Eligible Organ Donors (NCT04415658) | Washington University School of Medicine | 2020-12-01 |
| The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy (NCT04672252) | NYU Langone Health | 2020-12-01 |
| Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion (NCT03508804) | Stanford University | 2020-12-01 |
| Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 (NCT04667780) | Ayub Teaching Hospital | 2020-12-01 |
| Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease (NCT04311112) | Retinagenix Holdings | 2020-12-01 |
| A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder (NCT04598867) | ChemRar Research and Development Institute, LLC | 2020-12-01 |
| Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy (NCT04483687) | Gilead Sciences | 2020-12-01 |
| FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues (NCT05698082) | xiaoliang Huang | 2020-12-01 |
| Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment (NCT04679064) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-12-01 |
| Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine (NCT05166031) | Fidec Corporation | 2020-12-01 |
| Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 (NCT03848039) | Alessandro Ghelardi | 2020-12-01 |
| Convalescent Plasma as Adjunct Therapy for COVID-19 (NCT04873414) | National Institute of Health Research and Development, Ministry of Health Republic of Indonesia | 2020-12-01 |
| Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu (NCT02904304) | Ache Laboratorios Farmaceuticos S.A. | 2020-12-01 |
| Effectiveness of Fascia Iliaca Nerve Block for Post Hip Arthroscopy (NCT02717728) | Boston Children's Hospital | 2020-12-01 |
| Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain (NCT04572776) | Sorrento Therapeutics, Inc. | 2020-12-01 |
| A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) (NCT04598451) | argenx | 2020-12-01 |
| Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients (NCT04649697) | Cairo University | 2020-12-01 |
| Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure (NCT04642638) | Inovio Pharmaceuticals | 2020-11-30 |
| The Canada Lymph Node Score Project: A Crossover Trial (NCT04342377) | St. Joseph's Healthcare Hamilton | 2020-11-30 |
| Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. (NCT04642469) | AstraZeneca | 2020-11-30 |
| Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04620135) | Aerie Pharmaceuticals | 2020-11-30 |
| Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064) (NCT04635423) | Merck Sharp & Dohme LLC | 2020-11-30 |
| Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection (NCT04640233) | Dr. Reddy's Laboratories Limited | 2020-11-30 |
| Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) (NCT04299893) | Bernardino Clavo, MD, PhD | 2020-11-30 |
| The Prevent Severe COVID-19 (PRESECO) Study (NCT04600895) | Appili Therapeutics Inc. | 2020-11-30 |
| A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II (NCT04596540) | Swedish Orphan Biovitrum | 2020-11-30 |
| Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (NCT04466241) | ANRS, Emerging Infectious Diseases | 2020-11-27 |
| Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT) (NCT04184505) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2020-11-27 |
| Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (NCT04651790) | Pontificia Universidad Catolica de Chile | 2020-11-27 |
| Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 (NCT04780035) | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 2020-11-27 |
| A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease (NCT05811000) | Mediforum Ltd., Co. | 2020-11-27 |
| Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer (NCT04460352) | Karolinska University Hospital | 2020-11-27 |
| Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders (NCT05175131) | Abbott | 2020-11-27 |
| Bucillamine in Treatment of Patients With COVID-19 (NCT04504734) | Revive Therapeutics, Ltd. | 2020-11-27 |
| A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis (NCT04664959) | Samsung Bioepis Co., Ltd. | 2020-11-26 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) (NCT04544436) | Hoffmann-La Roche | 2020-11-26 |
| DNA Methylation Testing for the Screening of Uterine Cervical Lesion (NCT04646954) | Lei Li | 2020-11-26 |
| A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (NCT04616326) | Eli Lilly and Company | 2020-11-25 |
| A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (NCT04460885) | Novo Nordisk A/S | 2020-11-25 |
| Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients (NCT04737187) | Taiho Oncology, Inc. | 2020-11-25 |
| Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection (NCT04528888) | Massimo Girardis | 2020-11-25 |
| To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient (NCT05163756) | Daewon Pharmaceutical Co., Ltd. | 2020-11-25 |
| Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy (NCT04649203) | POLYSAN Scientific & Technological Pharmaceutical Company | 2020-11-25 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 (NCT04401475) | Edesa Biotech Inc. | 2020-11-25 |
| Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy (NCT04429022) | State University of New York at Buffalo | 2020-11-24 |
| A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia (NCT04511728) | Haisco Pharmaceutical Group Co., Ltd. | 2020-11-24 |
| Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT04516369) | Novartis Pharmaceuticals | 2020-11-24 |
| Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients (NCT04590586) | Amgen | 2020-11-24 |
| The Effect of Guanfacine on Delirium in Critically Ill Patients (NCT04578886) | University of Alabama at Birmingham | 2020-11-23 |
| Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (NCT04518995) | Concert Pharmaceuticals | 2020-11-23 |
| Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) (NCT04655625) | AnGes, Inc. | 2020-11-23 |
| Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. (NCT04629846) | Qilu Pharmaceutical Co., Ltd. | 2020-11-23 |